Genetic Analysis of 5 Alpha Reductase Type 2 Enzyme in Relation to Oxidative Stress in Cases of Androgenetic Alopecia in a Sample of Egyptian Population

    October 2013 in “ Our Dermatology Online
    Ossama Hussein Roshdy, Nagat Sobhy Mohammad, Eman Soliman Kamha, Marwa Omar
    Image of study
    TLDR 5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.
    This study analyzed the genetic polymorphism of the 5α reductase type 2 enzyme in relation to oxidative stress in cases of androgenetic alopecia (AGA) in a sample of the Egyptian population. The study found a possible association between AGA and the V89L genetic polymorphism of 5-alpha reductase type II enzyme, with patients carrying the mutant leucine (L) allele having a higher risk for developing AGA. Additionally, there was a possible association between AGA and oxidative stress, with a significant increase in the level of superoxide dismutase and catalase in patients compared to the control group. The study provides insight into the genetic factors and oxidative stress involved in AGA in the Egyptian population.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 90 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

    Similar Research

    5 / 1000+ results